Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Supplement—December 2017
Global Health Security Supplement

Ebola Response Impact on Public Health Programs, West Africa, 2014–2017

Barbara J. MarstonComments to Author , E. Kainne Dokubo, Amanda van Steelandt, Lise Martel, Desmond Williams, Sara Hersey, Amara Jambai, Sakoba Keita, Tolbert G. Nyenswah, and John T. Redd
Author affiliations: US Centers for Disease Control and Prevention, Atlanta, Georgia, USA (B.J. Marston, E.K. Dokubo, A. van Steelandt, L. Martel); US Centers for Disease Control and Prevention, Monrovia, Liberia (D. Williams); US Centers for Disease Control and Prevention, Freetown, Sierra Leone (S. Hersey); Ministry of Health and Sanitation, Freetown (A. Jambai); Ministry of Health, Conakry, Guinea (S. Keita); Ministry of Health, Monrovia (T.G. Nyenswah); US Centers for Disease Control and Prevention, Albuquerque, New Mexico, USA (J.T. Redd)

Main Article

Table 1

Timeframe for establishment or reestablishment of capacity to test for key notifiable diseases in Liberia after 2014–2015 Ebola outbreak and response*

IDSR priority disease Q1 2016 Q2 2016 Q3 2016 Q4 2016 Q1 2017
Acute flaccid paralysis Sent to WHO/regional laboratory outside Liberia for testing
Acute watery diarrhea (cholera) § §
Acute bloody diarrhea (shigella) § §
Human rabies Sent to WHO/regional Laboratory outside Liberia for testing
Lassa fever § §
Measles § § § §
Meningitis §
Neonatal tetanus Not applicable; diagnoses based on clinical symptoms
Viral hemorrhagic fever (including Ebola virus disease) § § § § §
Yellow fever § § § §

*IDSR, Integrated Disease Surveillance and Response framework; Q, quarter, WHO, World Health Organization.
†Capacity was not available during the specified quarter.
‡Capacity was partially established.
§Established laboratory capacity.

Main Article

Page created: November 20, 2017
Page updated: November 20, 2017
Page reviewed: November 20, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.